3 completed, 1 terminated, 1 withdrawn. 5 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 3, Terminated 1, Withdrawn 1 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow Minerals: new trials by email Literature Review of Minerals trials Research Report on Minerals
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Multi Vitamin and Mineral Supplementation of Liver Enzymes and Sonography in Patient With NAFLD Multiviamins and minerals, Placebo - Non-Alcoholic Fatty Liver Disease | Phase 1 | Completed | Sulaimani Polytechnic University | 160 | 2023-02-01 | 2023-06-09 |
| Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Hydroxychloroquine, Vitamins and Minerals, Azithromycin - Covid19, SARS (Severe Acute Respiratory Syndrome) | Phase 1 | Withdrawn | International Brain Research Foundation | 2020-11-01 | 2021-12-07 | |
| Micronutrients for Attention-Deficit Hyperactivity Disorder in Youth (MADDY) Study Broad Spectrum Micronutrients; a 36-ingredient blend of vitamins, minerals, amino acids, and antioxidants, Placebo - Attention Deficit Hyperactivity Disorder | Phase 1 / Phase 2 | Completed | Oregon Health and Science University | 135 | 2018-04-23 | 2023-02-08 |
| Study of Glaucoma Treatment With Food Additives Vitamins, minerals and medical herbs - Glaucomatous Neuropathy | Phase 1 / Phase 2 | Terminated | Future Products Management | 25 | 2005-09-01 | 2009-03-11 |
| A Pilot Study of Lycopene Supplementation in Prostatic Intraepithelial Neoplasia - Lyc-O-Mato (dietary supplement, 30 mg lycopene/day), - Certagen (multivitamins with minerals) - Prostatic Intraepithelial Neoplasia | Phase 1 | Completed | University of Pittsburgh | 80 | 2003-07-01 | 2015-05-27 |
Attention Deficit Disorder with Hyperactivity (1) · COVID-19 (1) · Impulsive Behavior (1) · Non-alcoholic Fatty Liver Disease (1) · Prostatic Intraepithelial Neoplasia (1) · Severe Acute Respiratory Syndrome (1)
Future Products Management (1) · International Brain Research Foundation (1) · Oregon Health and Science University (1) · Sulaimani Polytechnic University (1) · University of Pittsburgh (1)
Canada (1) · Iraq (1) · Israel (1) · Trinidad and Tobago (1) · United States (1)
Clareann H Bunker, PhD (1) · Hani Levkovitch-Verbin, MD (1) · Jeanette Johnstone (1) · Lewis H Kuller, MD (1) · Meir Gorban, MD (1) · Philip DeFina, PhD (1)
PMID 31763491, PMID 34303786, PMID 35770861, PMID 40772654, PMID 41776068